Curis Lifesciences Ltd (CURIS) Share Price & Fundamentals

What we do

Curis Lifesciences manufactures pharmaceutical products including tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments for domestic and global markets.

Founded in

2,010

Market share

-

Problem solved

Provides high-quality pharmaceutical manufacturing services enabling marketers to supply various medicinal forms efficiently.

Top clients or who we serve

Serves pharmaceutical marketers like Arova Pharma, Express Pharmaceuticals, J.B. Chemicals; primarily B2B.

Key management

-

Our journey and innovations

Started as Loreto Pharmaceuticals in 2010; converted to private limited in 2016 and public company in 2024. Manufacturing plant commissioned in 2017 with significant capacity.

Where we operate

India with clients across domestic and global pharmaceutical markets.

Top products or what we offer

Tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments.

Top brands

-

Raw materials needed

Active pharmaceutical ingredients and excipients for manufacturing various dosage forms.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue mainly from product-to-product manufacturing contracts; subject to pharma market demand cycles.

Our industry position

-

Financial highlights

Fiscal Year 2024-25 Revenue: Rs 49.13 Crore; Net Profit: Rs 6.11 Crore.

Geographical revenue split

-

Order book

-

Whats driving growth

Expanding manufacturing capacity with reputed pharma clients; new product launches; IPO capital infusion.

Our future plans

-

Our green promise

-

Our people and values

-

Key challenges ahead

-

Interesting facts

-

Risks and strategy

-